Ublituximab Mitigates Wearing-Off Effect and Improves B-Cell Depletion Among Participants Transitioning from Ocrelizumab: Updates from the ENHANCE Study

Drug Category :
Conference Category :
Lead Author : Singer B, et al.
Published Date : 21/10/2026
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2026/10/ENHANCE-Part-A_Poster_Final_ECTRIMS-2026.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top